Brachytherapy

Papers
(The TQCC of Brachytherapy is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Patient-controlled epidural analgesia, patient-controlled intravenous analgesia, and conventional intravenous opioids for gynecologic interstitial brachytherapy: A single-center retrospective study29
Masthead28
Editorial Board28
Patient assessment of lower urinary tract symptoms using the international prostate symptom score following low-dose-rate prostate brachytherapy25
Biochemical outcome of prostate cancer patients treated with hypofractionated external radiation and a single high-dose-rate brachytherapy boost23
HDR brachytherapy combined with external beam radiotherapy for unfavorable localized prostate cancer: A single center experience from inception to standard of care20
Mature effectiveness and toxicity outcomes associated with three treatment schedules of high-dose-rate brachytherapy monotherapy for favorable-risk prostate cancer18
Development and implementation of a 3d-HDR brachytherapy program for cervical cancer in a sub-Saharan African centre14
Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer14
3D-printed radiopaque episcleral plaques with radioactive collimating cavities for enhanced dose delivery in brachytherapy12
High-dose-rate brachytherapy with surface applicator in penile cancer10
Evaluating the relationship between vaginal apex “dog ears” and patterns of recurrence in endometrial cancer following adjuvant image guided vaginal cuff brachytherapy10
“Erratum to keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy” [Brachytherapy Volume 23, ISSUE 2, P188-198, March 2024]10
Editorial Board10
PSOR4  Presentation Time: 11:45 AM9
Editorial Board9
PSOR5  Presentation Time: 11:50 AM9
Masthead9
PHSPP02  Presentation Time: 2:40 PM9
Masthead9
PO148
PSOR8  Presentation Time: 12:05 PM8
PO35  Presentation Time: 10:30 AM8
Saturday, June 18, 20227:40 AM - 5:00 PMPO22  Presentation Time: 7:40 AM8
PO29  Presentation Time: 7:40 AM8
PO50  Presentation Time: 10:00 AM7
Saturday, June 18, 20222:00 PM - 3:00 PM PL01  Presentation Time: 2:00 PM7
ABS21 Author Index7
MSS07  Presentation Time: 4:15 PM7
Editorial Board7
Saturday, June 18, 20223:45 PM - 4:45PM MSS01  Presentation Time: 3:45 PM7
PO51  Presentation Time: 10:00 AM7
PO556
PO026
PO706
PO226
GSOR21  Presentation Time: 12:10 PM6
GSOR7  Presentation Time: 9:30 AM6
PO446
PO576
PO246
PO316
PO626
PO166
PP11  Presentation Time: 11:10 AM6
GSOR5  Presentation Time: 9:20 AM6
PP08  Presentation Time: 10:40 AM6
PO636
PO066
PO756
PO786
PO096
GSOR2  Presentation Time: 9:05 AM6
MSS10  Presentation Time: 4:30 PM6
PO476
MSOR11 Presentation Time: 10:50 AM5
PHSOR02 Presentation Time: 10:05 AM5
PLEN03 Presentation Time: 1:45 PM5
MSOR03 Presentation Time: 10:10 AM5
PO555
PP08 Presentation Time: 11:10 AM5
PP15 Presentation Time: 3:48 PM5
PHSOR04 Presentation Time: 10:15 AM5
PP12 Presentation Time: 11:50 AM5
PO545
PP05 Presentation Time: 10:40 AM5
PP13 Presentation Time: 3:30 PM5
PP18 Presentation Time: 4:15 PM5
MSOR01 Presentation Time: 10:00 AM5
MSOR08 Presentation Time: 10:35 AM5
PO575
PP07 Presentation Time: 11:00 AM5
PO485
MSOR5  Presentation Time: 5:05 PM4
PP11 Presentation Time: 11:30 AM4
GSOR03  Presentation Time: 12:10 PM4
GSOR10  Presentation Time: 12:45 PM4
PRSOR02 Presentation Time: 12:05 PM4
PLEN02 Presentation Time: 1:30 PM4
MSOR07  Presentation Time: 9:00 AM4
PSOR12  Presentation Time: 5:25 PM4
PSOR03  Presentation Time: 12:10 PM4
PHSOR04 Presentation Time: 10:15 AM4
GSOR02 Presentation Time: 2:35 PM4
PO874
Plenary Session Thursday, June 24, 2021 1:15 PM - 2:15 PM PLEN01 Presentation Time: 1:15 PM4
MSOR11  Presentation Time: 5:35 PM4
PP15 Presentation Time: 3:48 PM4
PP21 Presentation Time: 3:40 PM4
PP02  Presentation Time: 4:39 PM4
PO054
PRSOR11 Presentation Time: 12:50 PM4
MSOR06 Presentation Time: 10:15 AM4
PO123
Editorial Board3
PO323
PO933
PO1263
PO1073
PO943
GSOR03 Presentation Time: 2:40 PM3
GSOR11 Presentation Time: 3:20 PM3
Table of Contents3
PO353
PO203
PO053
PRSOR04 Presentation Time: 12:15 PM3
PRSOR02 Presentation Time: 12:05 PM3
PO1043
PO1083
GSOR01 Presentation Time: 2:30 PM3
PO103
Editorial Board3
Artificial intelligence applications in brachytherapy: A literature review3
Age, racial, and ethnic disparities in reported clinical studies involving brachytherapy3
PO163
PRSOR06 Presentation Time: 12:25 PM3
PO043
PP37 Presentation Time: 11:50 AM3
PRSOR01 Presentation Time: 12:00 PM3
PO1153
PO1053
PO1173
GSOR09 Presentation Time: 3:10 PM3
Table of Contents3
Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit3
PO223
Feasibility of quantitative diffusion-weighted imaging during intra-procedural MRI-guided brachytherapy of locally advanced cervical and vaginal cancers2
PHSOR06 Presentation Time: 9:25 AM2
Embracing a future of progress in gynecologic brachytherapy2
PO03062
MSOR07 Presentation Time: 8:30 AM2
PP03 Presentation Time: 4:18 PM2
PP05 Presentation Time: 4:36 PM2
Thursday, July 11, 20249:00 AM - 10:00 AMGPP01 Presentation Time: 9:00 AM2
MPP02 Presentation Time: 4:09 PM2
PPP03 Presentation Time: 10:48 AM2
MPP04 Presentation Time: 4:27 PM2
PO02472
Morbidity following image-guided brachytherapy for cervical cancer: Patient and treatment related factors2
PO02442
Breast brachytherapy: Building a bright future on the foundation of a rich history of advancement in technology, technique, and patient-centered care2
PSOR03 Presentation Time: 11:40 AM2
Masthead2
Thursday, July 11, 202410:30 AM - 11:30 AMPPP01 Presentation Time: 10:30 AM2
Editorial Board2
Author Index2
Comparison of AUA and phoenix definitions of biochemical failure following permanent brachytherapy for prostate cancer2
Editorial Board2
PO02242
BP02 Presentation Time: 4:09 PM2
GSOR02 Presentation Time: 11:35 AM2
Thursday, July 11, 20244:00 PM - 5:00 PM MPP01 Presentation Time: 4:00 PM2
PO04042
BP08 Presentation Time: 5:03 PM2
PO02562
PPP03 Presentation Time: 10:48 AM2
PO04172
First clinical implementation of GammaTile permanent brain implants after FDA clearance2
PO04252
Table of Contents2
GPP06 Presentation Time: 9:45 AM2
Effects of pain management using nonsteroidal anti-inflammatory drug suppositories during brachytherapy for cervical cancer: A single-center prospective observational study2
A multipurpose brachytherapy catheter to enable intratumoral injection2
PO03242
PO04062
PO02502
PPP02 Presentation Time: 10:39 AM2
Thursday, July 11, 20245:00 PM - 6:00 PM GSOR01 Presentation Time: 5:00 PM2
PO02532
PHSOR09 Presentation Time: 9:40 AM2
PPP04 Presentation Time: 10:57 AM2
GSOR04 Presentation Time: 5:15 PM2
PO02172
Iodine-125 brachytherapy for a desmoid tumor in the abdomen-thorax: A retrospective study2
GYN Posters PO02012
Editorial Board2
PO01202
PP01 Presentation Time: 10:00 AM1
Table of Contents1
PO201
Editorial Board1
PO241
Table of Contents1
PO791
Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma1
PSOR05 Presentation Time: 11:50 AM1
PL02  Presentation Time: 1:45 PM1
Re: Letter to the editor with regards to “Impact of detector selection on commissioning of Leipzig surface applicators with improving immobilization in high-dose-rate brachytherapy” by Li et al.1
Dosimetry and Monte Carlo modelling of the Papillon+ contact X-ray brachytherapy device1
Masthead1
Definitive radiation for advanced cervix cancer is not associated with vaginal shortening—a prospective vaginal length and dose correlation1
MSOR8  Presentation Time: 5:20 PM1
Validation of a commercial software dose calculation for Y-90 microspheres1
GSOR05  Presentation Time: 12:20 PM1
Factors associated with late local failure and its influence on survival in men undergoing prostate brachytherapy1
PP06  Presentation Time: 9:05 AM1
Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities1
Editorial Board1
Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial1
CT-guided iodine-125 brachytherapy is an effective palliative treatment for the right lower paratracheal lymph nodes metastasis previously treatment failure1
Feasibility of electronic brachytherapy in cervix cancer–A dosimetric comparison of different brachytherapy techniques1
Gastrointestinal Brachytherapy1
PP04 Presentation Time: 10:30 AM1
Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy1
PO231
High-dose-rate brachytherapy for airway malignancy a single institution experience1
PO501
Dosimetric study of Varian Universal Multi-Channel Cylinder System for High-Dose-Rate 192Ir Brachytherapy1
PP02  Presentation Time: 9:29 AM1
Response to letter to the editor with regards to “Impact of detector selection on commissioning of Leipzig surface applicators with improving immobilization in high-dose-rate brachytherapy” by Li et a1
PO02511
MSOR2  Presentation Time: 4:50 PM1
Table of Contents1
Focal injection of a radiopaque viscous spacer before focal brachytherapy as re-irradiation for locally recurrent prostate cancer1
Determination of Ir-192 micrselectron-V2 HDR/PDR dwell position reproducibility using a slit camera1
Development and clinical implementation of simple needle attachment post placement interstitial template (SNAPP-IT) enabling a shorter, more direct needle path while preserving tumor visualization1
MSOR03  Presentation Time: 8:40 AM1
Complications and side effects of high-dose-rate prostate brachytherapy1
GSOR04  Presentation Time: 12:15 PM1
Change in vaginal length and sexual function in women who undergo surgery ± radiation therapy for endometrial cancer1
Table of Contents1
Redefining the role of pulsed-dose-rate brachytherapy in cervical cancer treatment using a preplanned approach1
Long-term disease-free survival following salvage brachytherapy for recurrent pediatric rhabdomyosarcoma: Two case reports and review of relevant literature1
Local seed displacement from Day 0 to Day 30 in I-125 permanent prostate brachytherapy: A detailed, computed tomography-based analysis1
Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience1
Radiation dose rate variations in different measurement scenarios after prostate 125I brachytherapy1
Therapeutic and prophylactic effects of radiation therapy in the management of recurrent granulation tissue induced tracheal stenosis: a review on the role of Endobronchial brachytherapy and external 1
PO131
PP05  Presentation Time: 5:06 PM1
PO211
Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II tri1
Optimizing surface mould brachytherapy for treatment of nasal basal cell carcinoma using customized applicators1
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer1
Thursday, June 22, 20234:30 PM - 5:30 PMPP01 Presentation Time: 4:30 PM1
A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques1
After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a po1
MSOR7  Presentation Time: 5:15 PM1
Table of Contents1
Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series1
PO351
PP03  Presentation Time: 11:18 AM1
Redefining bladder neck dose in low-dose-rate prostate brachytherapy–Can we improve urinary toxicity without impacting disease control?1
Underutilization of brachytherapy for cervical cancer in the United States1
Prostate size, source configuration, and dosimetry dynamics of stranded 125I seed implants1
PO681
Coronary intravascular brachytherapy for in-stent restenosis: A review of the contemporary literature1
Evaluation and improvement of the safety of 3D-printed template assisted intracavitary/interstitial brachytherapy for cervical cancer using repeat FMEA1
Complications of intracavitary brachytherapy for gynecologic cancers and their management: A comprehensive review1
CivaSheet intraoperative radiation therapy for pancreatic cancer1
0.11169099807739